Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04132466 · ClinicalTrials.gov registry record · NA
ASSURE WCD Clinical Evaluation - Conversion Efficacy Study
A NA study, sponsored by Kestra Medical Technologies.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT04132466 is a NA study that has completed, run by Kestra Medical Technologies. The registered enrollment target is 13 participants.
The verdict
NCT04132466, a NA study, has completed, sponsored by Kestra Medical Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
A multicenter single arm open label evaluation of the ASSURE Wearable Cardioverter Defibrillator (WCD) defibrillation waveform in adult cardiac patients
Interventions
- DEVICE Defibrillation using the ASSURE wearable cardioverter defibrillator therapy delivered via a waveform delivery test system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-11-25 |
| Est. Completion | 2020-03-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04132466
The ClinicalTrials.gov registry entry for NCT04132466 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kestra Medical Technologies, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Defibrillation using the ASSURE wearable cardioverter defibrillator therapy delivered via a waveform delivery test system is the first listed.
NCT04132466 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04132466 about?
NCT04132466 is a clinical study titled "ASSURE WCD Clinical Evaluation - Conversion Efficacy Study". A multicenter single arm open label evaluation of the ASSURE Wearable Cardioverter Defibrillator (WCD) defibrillation waveform in adult cardiac patients
What is the current status of trial NCT04132466?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2019-11-25. Estimated completion is 2020-03-19.
What interventions are being tested in trial NCT04132466?
The interventions under investigation include: Defibrillation using the ASSURE wearable cardioverter defibrillator therapy delivered via a waveform delivery test system (DEVICE).
Who is sponsoring clinical trial NCT04132466?
This trial is sponsored by Kestra Medical Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.